UK scientist and children's author wins EMBO Award for Communications 2004

November 09, 2004

Fran Balkwill, Professor of Cancer Biology at the Barts & The London, Queen Mary's Medical School, is the 2004 winner of the EMBO Award for Communication in the Life Sciences. Balkwill receives the award in recognition of her outstanding contribution to science communication for children. The cancer researcher has authored 13 children's books that take a novel look at a range of topics from genetics to HIV and AIDS. Balkwill is also the Director of the 'Centre of the Cell', an exciting new interactive bioscience centre in London's East End.

The EMBO Award for Communication is presented annually to a practising life scientist in Europe who has made significant contributions to public understanding of science. The award highlights the exceptional efforts made by many scientists to combine science communication activities with a full-time research career. Winners of the EMBO Communications Award are also put forward for the European Commission's Descartes Prize for Science Communication.

The International jury applauded Balkwill for 'her spectacular work in communicating important scientific concepts to the young and her untiring efforts to bring critical science and health messages to deprived communities'. The prize of Euro 5,000 and a handcrafted gold and silver medal were presented to Fran Balkwill on November 5, 2004 at the EMBL/EMBO Science & Society Conference, "Time and Aging - Mechanisms and Meanings" in Heidelberg, Germany.

Frances Balkwill said: "I am delighted to receive this award, but I don't look on it as an individual achievement. Without illustrator, Mic Rolph, the books would never have been a success and there are numerous other people in the UK, Europe, South Africa and the US, who have helped and inspired me. The award is a great honour and I hope it will help stress the importance of science education for the young and bring attention to the plight of children at risk of HIV in Africa today."

As well as her full-time role as a researcher and Director of the Cancer Research UK Translational Oncology Centre at Queen Mary, Fran Balkwill is a dedicated science communicator. She has written 13 acclaimed children's books including the prize-winning Cells Are Us and Cell Wars. Illustrated by Mic Rolph, the books combine punchy narrative with lively graphics, taking readers on a journey through the wonders of biology. The latest two books, although equally entertaining, have a far more profound aim - saving lives. Staying Alive: Fighting HIV/AIDS and the revised edition, You, Me and HIV are aimed at educating children at risk of contracting HIV in Africa.

Research for Balkwill and Rolph's first book on HIV and Aids took the author and illustrator to South Africa, where they talked to children, teachers and health care professionals to determine the educational needs of the local communities. Funding for the project was organised by Siamon Gordon of Oxford University, who also came up with the original idea in 2000. In 2002, in collaboration with Cold Spring Harbor Laboratory Press, 19,000 copies of Staying Alive: Fighting HIV/AIDS were distributed free of charge throughout South Africa.

The second edition, You, Me and HIV, also published by Cold Spring Harbor Laboratory Press, is the result of a further trip to South Africa to assess the impact of the first book and incorporates revisions from teachers, students and community workers who have been working with the book. You, Me and HIV will be available from January 2005 and thanks to funding from the Bill and Melinda Gates Foundation, will reach 100,000 more children and educators in sub-Saharan Africa.

Since 2001 Frances Balkwill has also been the driving force behind another major science education project much closer to home. Housed within the new building for Bart's and The London, Queen Mary's School of Medicine in London's East End, the Centre of the Cell will open its doors to children, teenagers and teachers from the surrounding areas in April 2006. The Centre of the Cell is the first science education centre to be located within a medical school with working research laboratories. The aim is to allow visitors to experience the 'real thing' and draw them into the exciting world of biomedical research through a series of interactive exhibits and hands-on activities.

Deadline for 2005 EMBO Award for Communication in the Life Sciences: May 31, 2005
About EMBO
The European Molecular Biology Organisation (EMBO) promotes biosciences in Europe. Through initiatives such as fellowships, courses and workshops, EMBO supports transnational mobility, training and exchange at all stages of the scientific career. The organisation was founded in 1964 and an example of its early impact was the establishment of the well-known laboratory, EMBL. EMBO elects new members annually on the basis of proven excellence in research. Today the organization has approximately 1200 European members and 100 associate members worldwide including some 38 Nobel Laureates.

About the Barts and The London, Queen Mary's School of Medicine and Dentistry
Created from two historic medical schools: St Bartholomew's Hospital Medical College (Barts, established in 1843) and the Royal London Hospital Medical College (The London, England's oldest medical college established in 1785), the School of Medicine and Dentistry moved into a new phase in 1995 with the merger of these famous clinical schools with Queen Mary, University of London. The School has a strong tradition of providing high quality, state-of-the-art undergraduate education and an acclaimed reputation in clinical, medical and health research.


Lindsay Johnson
Communications Officer
Postfach 102240
D-69012 Heidelberg

Tel: 49-6221-8891-108
Fax: 49-6221-8891-200

Queen Mary's School of Medicine and Dentistry
Sally Webster
Deputy Head of Press & PR
External Relations & Communications Department
Queen Mary, University of London
Mile End Road
E1 4NS

Tel: 44-20-7882-5404

Further information

European Molecular Biology Laboratory

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to